U.S. Secondary Hyperparathyroidism (SHPT) Treatment Market Size, Share, Growth Analysis, By Drug Class Analysis(Calcimimetics, Vitamin D Analogues), By Distribution Channels(Hospital & Retail Pharmacies, Online Channel) - Industry Forecast 2023-2030

US Secondary Hyperparathyroidism (Shpt) Treatment Market size was valued at USD 4.7 billion in 2021 and is poised to grow from USD 5.4 billion in 2022 to USD 7.5 billion by 2030, growing at a CAGR of 6.5% in the forecast period (2023-2030).

2021年，美国继发性甲状旁腺功能亢进症（Shpt）治疗市场规模达到47亿美元，预计将从2022年的54亿美元增长至2030年的75亿美元，在预测期内（2023-2030年）的复合年增长率将达到6.5%。